WallStSmart

HealthEquity Inc (HQY)vsZhongchao Inc (ZCMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 9913% more annual revenue ($1.31B vs $13.12M). HQY leads profitability with a 16.4% profit margin vs -13.0%. HQY earns a higher WallStSmart Score of 68/100 (B-).

HQY

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 10.0Quality: 6.5
Piotroski: 4/9

ZCMD

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 9.29
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HQYUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$115.13

Current Price

$82.47

$32.66 discount

UndervaluedFair: $115.13Overvalued

Intrinsic value data unavailable for ZCMD.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HQY3 strengths · Avg: 8.7/10
EPS GrowthGrowth
92.4%10/10

Earnings expanding 92.4% YoY

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

ZCMD3 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.2910/10

Safe zone — low bankruptcy risk

Areas to Watch

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

ZCMD4 concerns · Avg: 2.3/10
Market CapQuality
$6.96M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-5.9%2/10

ROE of -5.9% — below average capital efficiency

Revenue GrowthGrowth
-32.9%2/10

Revenue declined 32.9%

EPS GrowthGrowth
-91.0%2/10

Earnings declined 91.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : HQY

The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bull Case : ZCMD

The strongest argument for ZCMD centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Bear Case : ZCMD

The primary concerns for ZCMD are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

HQY profiles as a mature stock while ZCMD is a turnaround play — different risk/reward profiles.

HQY carries more volatility with a beta of 0.32 — expect wider price swings.

HQY is growing revenue faster at 7.3% — sustainability is the question.

HQY generates stronger free cash flow (102M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (68/100 vs 29/100), backed by strong 16.4% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Zhongchao Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · China

Zhongchao Inc. provides health care information, education and training services in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?